Norton Rose Fulbright advises a broad range of clients in the life sciences sector, including pharma and medical device companies, bioscience and biotech businesses, retail pharmacies, wholesale distributors, food tech companies, and investors such as venture capital and private equity firms. The firm focuses on litigation affecting participants across the sector, but also handles regulatory and commercial matters. D’Lesli Davis, head of life sciences and healthcare, serves as lead trial counsel for pharma and medical device clients in mass tort cases, including multidistrict litigation and consolidated proceedings in state and federal courts. Jonathan Skidmore, global co-head of life sciences and healthcare, focuses on matters involving pharma products, medical products, and device liability, with substantial experience representing clients in complex mass tort litigation. Both lawyers mentioned above are based in Dallas.
Legal 500 Editorial commentary
Key clients
- Alcon Inc.
- Sanctum Therapeutics Corporation
- Takeda Pharmaceutical Company, Ltd.
- Eli Lilly and Company
- Cincinnati Children’s Hospital Medical Center
- McKesson Corporation
- Bausch Health US, LLC
- Salix Pharmaceuticals, Inc
- Hikma Pharmaceuticals PLC
- Johnson & Johnson
Work highlights
Advised Alcon Inc. in its merger agreement to acquire LENSAR, Inc.
Advised Sanctum Therapeutics Corp. in its merger with Adnexus Biotechnologies Inc.
Overseeing the management, expansion, and prosecution of the complete patent portfolio for Cincinnati Children’s Hospital Medical Center’s Center for Stem Cell & Organoid Medicine (CuSTOM) Division.
Practice head
D’Lesli M. Davis; Jonathan Skidmore